defin
diarrhea
passag
three
loos
liquid
stool
per
day
frequent
normal
individu
diarrhea
lead
caus
mortal
among
children
year
age
account
one
ten
child
death
worldwid
annual
disproport
affect
young
children
lowand
middleincom
countri
figur
billion
episod
diarrhea
million
progress
sever
episod
estim
death
due
diarrhea
incid
mortal
diarrhea
pneumonia
vari
age
figur
burden
diseas
mainli
concentr
younger
age
group
epidemiolog
childhood
diarrhea
pneumonia
overlap
like
share
risk
factor
undernutrit
suboptimum
breastfeed
zinc
defici
children
highest
risk
first
year
life
death
secondari
diarrhea
diarrheal
mortal
rate
declin
annual
diseas
incid
decreas
estim
episodeschildyear
episodeschildyear
highest
burden
diseas
remain
consist
respect
age
age
group
highest
incid
burden
mortal
due
diarrhea
children
less
year
age
highest
region
africa
southeast
asia
estim
third
sever
diarrhea
episod
prevent
vaccin
ie
rotaviru
cholera
furthermor
nutrit
key
underli
risk
factor
morbid
mortal
associ
diarrhea
pneumonia
diarrhea
diseas
sever
children
underf
mostli
mild
case
care
soughtno
dehydr
last
day
moder
case
care
soughtani
dehydr
present
case
sever
case
care
sought
sever
dehydr
present
last
day
older
children
adult
predominantli
mild
episod
moder
sever
among
individu
year
older
sever
episod
typic
last
day
caus
dehydr
case
despit
reduct
diarrheal
mortal
use
oral
rehydr
therapi
persist
global
burden
enter
infect
result
high
morbid
stunt
growth
affect
onefifth
children
worldwid
onethird
children
develop
countri
children
suffer
diarrhea
first
year
life
might
averag
cm
growth
shortfal
iq
point
decrement
time
year
old
propos
link
enter
infect
child
growth
develop
doubl
burden
enter
infect
malnutrit
potenti
link
factor
obes
later
life
interrel
tripl
burden
figur
import
risk
factor
diarrhea
includ
lack
exclus
breastfeed
infant
younger
month
undernutrit
zinc
defici
evid
suggest
vitamin
defici
increas
risk
sever
diarrhea
import
risk
factor
incid
diarrhea
associ
specif
water
sanit
risk
factor
ie
unwash
hand
poor
water
qualiti
diarrhea
morbid
mortal
shown
howev
outcom
inappropri
excreta
dispos
poor
avail
evid
permit
rough
estim
risk
stratifi
subgroup
infant
age
less
month
acut
lowerrespiratorytract
infect
risk
factor
diarrhea
measl
establish
risk
factor
diarrhea
studi
show
moder
coverag
measl
vaccin
infant
incid
diarrhea
could
reduc
diarrhea
mortal
reduc
children
younger
year
tabl
show
effect
size
specif
confirm
biolog
risk
factor
diarrhea
diarrhea
classifi
base
durat
prolong
acut
day
persist
day
prolong
diarrhea
classifi
prolongedacut
wateri
diarrhea
loos
wateri
stool
least
three
time
h
period
prolongedacut
invas
diarrhea
gross
blood
histori
inspect
stool
less
day
durat
typic
accompani
fever
diarrhea
secondari
one
follow
pathophysiolog
process
secretori
osmot
inflammatori
diarrhea
secretori
diarrhea
occur
signific
increas
volum
intestin
fluid
output
exce
reabsorpt
abil
gastrointestin
epithelium
research
initi
done
patient
cholera
reveal
secretori
diarrhea
cholera
lead
signific
fecal
water
electrolyt
loss
gut
still
retain
abil
reabsorb
water
electrolyt
due
intact
nacoupl
solut
cotransport
mechan
chloridemedi
secret
stimul
second
messeng
diarrheal
infect
secondari
vibrio
cholera
shigella
salmonella
escherichia
coli
strain
bacteri
pathogen
produc
enterocyt
receptor
bind
pathogen
caus
chloridemedi
secret
stimul
second
messeng
eg
camp
cgmp
calcium
import
recogn
may
combin
osmot
secretori
diarrhea
case
rotaviru
enterotoxin
mediat
secretori
diarrhea
along
osmot
diarrhea
secondari
enterocyt
damag
phosphorylationinduc
activ
increas
camp
cgmp
calcium
channel
set
exogen
endogen
substanc
exogen
mediat
includ
bacteri
toxin
cholera
shiga
toxin
parasit
endogen
mediat
endocrin
vasoact
intestin
peptid
serotonin
releas
immun
system
histamin
serotonin
prostaglandin
lastli
increas
intestin
permeabl
due
loss
cellular
tight
junction
lead
increas
intestin
fluid
loss
figur
poorli
absorb
osmot
activ
substanc
gut
lumen
retain
fluid
pull
water
secondarili
ion
maintain
osmot
equilibrium
bodi
fluid
key
underli
process
behind
osmot
diarrhea
occur
secondari
absorpt
defect
enzym
defici
pancrea
intestin
wall
caus
maldigest
andor
malabsorpt
osmot
gradient
creat
neutral
maintain
excess
amount
water
within
intestin
exampl
includ
malabsorpt
congenit
acquir
lactas
defici
glutensensit
enteropathi
celiac
diseas
maldigest
seen
pancreat
insuffici
figur
gastrointestin
barrier
disrupt
bacteria
salmonella
e
coli
campylobact
virus
rotavirus
coronavirus
protozoa
cryptosporium
giardia
addit
idiopath
inflammatori
bowel
diseas
common
caus
inflammatori
diarrhea
immun
cell
activ
releas
inflammatori
mediat
cytokin
stimul
secret
activ
enter
nerv
subepitheli
myofibroblast
destroy
basement
membran
metalloproteinas
damag
enterocyt
extrud
villou
atrophi
develop
follow
regen
crypt
hyperplasia
small
intestin
colon
surfac
cover
immatur
enterocyt
typic
defici
brush
border
enzym
transport
necessari
absorpt
nutrient
water
major
etiolog
prolongedacut
persist
diarrhea
outlin
repeat
persist
infect
figur
viciou
cycl
diseas
poverti
enter
infect
especi
first
year
life
without
overt
diarrhea
predispos
individu
malnutrit
stunt
growth
multipl
mechan
stunt
year
age
turn
associ
impair
cognit
develop
extend
later
childhood
even
adulthood
adult
product
addit
malnourish
children
experi
greater
frequenc
durat
diarrheal
ill
document
anim
model
heavier
infect
latter
document
cryptosporidium
enteroaggreg
e
coli
final
enter
infect
stunt
predispos
obes
comorbid
diabet
hypertens
cardiovascular
diseas
metabol
syndrom
burgeon
healthcar
expenditur
contribut
individu
societ
poverti
viciou
cycl
reproduc
guerrant
rl
deboer
md
moor
sr
scharf
rj
lima
aa
impoverish
gut
tripl
burden
diarrhoea
stunt
chronic
diseas
natur
review
gastroenterolog
hepatolog
despit
clinic
clue
determin
caus
agent
diarrhea
individu
patient
basi
clinic
ground
alon
difficult
acuteprolong
persist
diarrhea
similar
initi
evalu
manag
chapter
focus
assess
sever
ill
need
rehydr
brief
histori
direct
clinic
exam
help
determin
guid
manag
specif
point
histori
includ
time
onset
diarrhea
frequenc
amount
consist
content
blood
mucou
pu
stool
associ
sign
symptom
fever
abdomin
pain
nausea
vomit
bloat
flatu
tenesmu
recent
travel
dietari
histori
exposur
pet
cattl
drug
histori
specif
antibiot
lax
pertin
past
medic
surgic
histori
famili
histori
day
care
attend
persist
diarrhea
age
symptom
onset
detail
dietari
histori
relat
onset
symptom
introduct
new
food
relev
initi
physic
exam
focus
sign
symptom
dehydr
discuss
sepsi
fever
toxic
look
major
complic
acut
chronic
diarrhea
requir
urgent
manag
nutrit
assess
necessari
includ
height
weight
vital
sign
global
nutrit
appear
earli
recognit
dehydr
main
caus
mortal
critic
part
diarrhea
manag
loss
water
electrolyt
sodium
chlorid
potassium
bicarbon
via
liquid
stool
emesi
sweat
urin
breath
lead
dehydr
left
unreplac
suggest
assess
dehydr
scale
three
figur
earli
dehydr
sign
symptom
moder
dehydr
notabl
thirst
restless
irrit
behavior
decreas
skin
elast
sunken
eye
sever
dehydr
symptom
becom
sever
diminish
conscious
lack
urin
output
cool
moist
extrem
rapid
feebl
puls
low
undetect
blood
pressur
pale
skin
set
clinic
shock
acut
diarrhea
maintain
adequ
intravascular
volum
correct
fluid
electrolyt
disturb
take
prioriti
identif
caus
agent
stool
cultur
usual
unnecessari
immunecompet
patient
present
within
h
onset
acut
wateri
diarrhea
lab
test
includ
stool
studi
blood
test
intestin
imag
immunolog
serolog
evalu
indic
bloodi
diarrhea
high
fever
f
system
ill
sever
prolong
diarrhea
histori
suggest
food
poison
recent
histori
travel
oversea
possibl
immun
dysfunct
supplementari
laboratori
studi
includ
serum
electrolyt
assess
patient
acut
diarrhea
usual
unnecessari
dehydr
primari
caus
death
patient
diarrhea
effect
address
cornerston
diarrhea
treatment
oral
rehydr
solut
or
develop
research
south
asia
simpl
costeffect
solut
contain
glucos
electrolyt
use
prevent
treat
dehydr
due
diarrhea
caus
across
age
develop
or
took
advantag
glucosecoupl
intestin
sodium
transport
mechan
discov
robert
crane
absorpt
sodium
glucos
molecul
across
lumin
membran
facilit
protein
sodium
glucos
cotransport
although
nutrientindepend
sodium
absorpt
across
intestin
epitheli
brush
border
membran
impair
diarrhea
cotransport
sodium
glucos
preserv
allow
absorpt
sodium
thu
water
provid
orss
figur
enterocyt
transport
glucos
blood
facilit
glucos
transport
type
basolater
membran
na
atpas
provid
gradient
drive
process
key
success
use
or
rehydr
fact
physiolog
process
stay
intact
even
set
sever
diarrhea
figur
pathophysiolog
secretori
diarrhea
diarrhea
secondari
cholera
toxin
cholera
toxin
induc
secret
part
activ
intramur
neural
reflex
toxin
attach
enterochromaffin
cell
epithelium
caus
increas
camp
respons
latter
serotonin
neurotensin
nt
possibl
addit
peptid
releas
activ
affer
neuron
whose
axon
cours
close
epithelium
myenter
neural
plexu
connect
interneuron
ii
turn
releas
acetylcholin
ach
andor
substanc
p
sp
activ
secretomotor
neuron
iii
submucos
neural
plexu
axon
secretomotor
neuron
reach
epitheli
surfac
villu
crypt
region
releas
vip
therebi
stimul
secret
crypt
inhibit
nutrientindepend
salt
absorpt
villi
reproduc
field
intestin
ion
transport
pathophysiolog
diarrhea
journal
clinic
investig
origin
or
recommend
formul
total
osmolar
mmol
l
tabl
subsequ
investig
lead
current
recommend
low
osmolar
or
total
osmolar
mmol
l
decreas
concentr
glucos
sodium
current
formul
compar
origin
formul
associ
decreas
stool
volum
compar
origin
world
health
organizationunit
nation
children
fund
whounicef
or
solut
reduc
vomit
almost
reduc
need
unschedul
iv
therapi
review
muno
colleagu
assess
studi
show
univers
coverag
or
would
reduc
diarrhearel
death
two
phase
treatment
rehydr
mainten
rehydr
phase
quick
replac
fluid
deficit
h
achiev
clinic
hydrat
mainten
phase
mainten
calori
fluid
administ
reintroduct
enter
feed
ageappropri
unrestrict
diet
includ
solid
children
mild
moder
dehydr
ml
orskg
bodi
weight
h
administ
replac
estim
fluid
deficit
addit
or
administ
replac
ongo
loss
set
sever
dehydr
emerg
immedi
need
iv
rehydr
lactat
ringer
solut
normal
salin
similar
solut
administ
ml
kg
bodi
weight
puls
perfus
mental
statu
return
normal
zinc
defici
widespread
among
young
children
lowand
middleincom
countri
contribut
mortal
morbid
relat
diarrhea
malaria
pneumonia
restrict
growth
children
diarrhea
suffer
due
poor
baselin
dietari
zinc
intak
aggrav
net
loss
zinc
period
ill
unicef
recommend
zinc
treatment
diarrhea
sinc
evid
suggest
zinc
administr
mg
per
day
diarrhea
ceas
reduc
durat
sever
hospit
admiss
associ
diarrheal
episod
children
develop
countri
zinc
treatment
diarrhea
estim
decreas
diarrhea
mortal
well
significantli
reduc
sever
durat
diarrheal
episod
children
well
reduct
treatment
failur
death
diarrheal
episod
longer
durat
day
current
guidelin
manag
treatment
diarrhea
children
strongli
recommend
continu
feed
alongsid
appropri
manag
extens
review
feed
strategi
foodbas
intervent
children
younger
year
diarrhea
lowand
middleincom
countri
show
although
ill
durat
shorter
risk
treatment
failur
lower
children
acut
diarrhea
consum
lactosefre
diet
effect
lactos
avoid
stool
output
weight
gain
recommend
follow
antibiot
use
rel
mild
selflimit
infecti
diarrhea
minim
develop
drug
resist
diarrhea
hemorrhag
serious
dehydr
associ
seriou
system
sign
symptom
longer
day
durat
without
improv
antibiot
use
appropri
review
traa
colleagu
assess
effect
whorecommend
antibiot
ciprofloxacin
ceftriaxon
pivmecillinam
treatment
dysenteri
conclud
antibiot
expect
child
sever
classif
give
fluid
sever
dehydr
plan
c
child
also
anoth
sever
classif
refer
urgent
hospit
mother
give
frequent
sip
or
way
advis
mother
continu
breastfeed
advis
mother
continu
breastfeed
advis
mother
return
immedi
advis
mother
feed
child
persist
diarrhoea
give
multivitamin
miner
includ
zinc
day
advis
mother
return
immedi
decreas
diarrhea
mortal
attribut
dysenteri
evid
recommend
antibiot
use
reduct
morbid
mortal
due
cholera
shigella
spp
cryptosporidium
da
et
al
show
develop
countri
set
antibiot
manag
cholera
result
reduct
rate
clinic
failur
reduct
rate
bacteriolog
failur
also
show
antibiot
manag
shigella
result
reduct
rate
clinic
failur
reduct
rate
bacteriolog
failur
antibiot
treatment
cryptosporidiosi
reduc
mortal
rate
clinic
failur
rate
parasitolog
failur
empir
antibiot
regimen
determin
host
factor
sever
ill
local
resist
pattern
histori
travel
area
increas
resist
probiot
defin
joint
food
agricultur
organizationwho
work
group
live
microorgan
administ
adequ
amount
concern
health
benefit
host
recent
cochran
systemat
review
use
probiot
adjunct
therapi
or
shown
probiot
shorten
durat
diarrhea
reduc
stool
frequenc
observ
remain
inconclus
due
trial
small
number
particip
commonli
use
probiot
trial
includ
bifidobacterium
two
genera
lactic
acid
bacteria
lactobacillu
streptococcu
yeast
saccharomyc
insuffici
evid
recommend
widespread
use
time
vomit
associ
diarrhea
caus
signific
addit
physic
discomfort
concern
parent
physician
addit
vomit
limit
success
or
result
increas
use
intraven
iv
rehydr
need
prolong
emerg
depart
stay
hospit
recent
systemat
review
evalu
seven
rct
use
ondansetron
metoclopramid
dimenhydrin
dexamethason
children
age
year
found
use
antiemet
significantli
reduc
incid
vomit
hospit
reduc
iv
fluid
requir
cochran
review
use
antiemet
reduc
vomit
relat
acut
gastroenter
children
adolesc
conclud
oral
ondansetron
increas
proport
patient
ceas
vomit
reduc
number
need
iv
rehydr
immedi
hospit
admiss
iv
ondansetron
metoclopramid
reduc
number
episod
vomit
hospit
admiss
dimenhydrin
suppositori
reduc
durat
vomit
antiemet
effect
manag
gastroenter
children
potenti
decreas
morbid
mortal
burden
due
diarrhea
breast
milk
provid
variou
immunolog
psycholog
social
econom
environment
benefit
therefor
recommend
best
feed
option
newborn
babi
young
infant
develop
countri
includ
hivinfect
popul
lamberti
colleagu
review
studi
develop
countri
report
effect
breastfeed
diarrhea
morbid
mortal
investig
estim
breastfeed
associ
increas
diarrhea
incid
mortal
rotaviru
common
caus
sever
dehydr
diarrhea
infant
worldwid
rotaviru
vaccin
repres
import
prevent
approach
reduc
burden
diarrheal
diseas
due
rotaviru
sinc
two
rotaviru
vaccin
current
licens
vaccin
infant
north
south
american
european
eastern
mediterranean
countri
merck
glaxosmithklin
live
oral
vaccin
contain
five
reassort
rotavirus
develop
human
bovin
parent
rotaviru
strain
given
oral
three
dose
age
month
live
oral
vaccin
licens
use
unit
state
contain
human
rotaviru
strain
given
oral
two
dose
age
month
first
dose
either
vaccin
effect
given
child
week
age
children
receiv
dose
rotaviru
vaccin
turn
month
old
global
health
set
evid
suggest
rotaviru
vaccin
efficaci
may
vari
set
due
region
differ
circul
rotaviru
vaccin
strain
reduc
efficaci
oral
vaccin
countri
high
burden
malnutrit
enter
infect
metaanalys
muno
et
al
assess
effect
two
current
market
vaccin
pentaval
humanbovin
reassort
rotaviru
vaccin
monoval
attenu
human
rotaviru
vaccin
phase
iii
trial
european
latin
american
site
vaccin
well
unit
state
includ
navajo
apach
popul
taiwanes
site
pentaval
vaccin
effect
studi
monoval
pentaval
vaccin
conduct
northern
australia
nicaragua
respect
author
estim
rotaviru
vaccin
could
prevent
although
case
manag
oral
rehydr
therapi
substanti
improv
casefat
rate
cholera
infect
still
kill
rapidli
especi
outbreak
set
oldgener
inject
cholera
vaccin
abandon
sinc
restrict
effect
local
side
effect
howev
studi
shown
vaccin
effect
reduc
risk
cholera
infect
children
younger
year
increas
vibriocid
antibodi
rel
risk
one
advers
event
evid
effect
oral
cholera
vaccin
make
good
candid
cholera
control
endem
area
maintain
water
qualiti
protect
treatment
water
sourc
point
use
effect
improv
water
suppli
improv
sourc
water
improv
distribut
cairncross
colleagu
estim
effect
water
sanit
hygien
strategi
estim
risk
reduct
diarrhea
hand
wash
soap
improv
water
qualiti
proper
excreta
dispos
although
evid
confirm
efficaci
effect
mani
intervent
mani
intervent
access
peopl
need
henc
focu
deliveri
strategi
increas
one
method
communitybas
case
manag
provid
amen
commun
health
worker
home
visit
communitybas
session
educ
promot
care
seek
approach
assess
conclud
communitybas
intervent
associ
signific
increas
use
or
increas
use
zinc
diarrhea
furthermor
find
show
increas
care
seek
diarrhea
note
signific
declin
inappropri
use
antibiot
diarrhea
lancet
childhood
pneumonia
diarrhea
seri
review
exist
prevent
therapeut
intervent
could
role
reduc
morbid
mortal
burden
children
younger
year
due
diarrhea
pneumonia
intervent
maximum
effect
includ
breastfeed
or
commun
case
manag
seri
conclud
despit
larg
global
burden
childhood
diarrhea
pneumonia
death
avoid
intervent
deliv
scale
prevent
death
figur
estim
model
live
save
tool
show
intervent
scale
countdown
countri
diarrheal
pneumonia
death
children
younger
year
prevent
scale
diarrheal
pneumonia
intervent
would
cost
us
billion
billion
present
level
spend
assess
need
costeffect
intervent
nation
health
deliveri
framework
clear
idea
effect
intervent
diarrhea
pneumonia
commun
healthwork
program
increasingli
employ
reach
underserv
popul
real
opportun
exist
scaleup
commun
advocacyeduc
program
earli
case
detect
manag
strategi
seri
also
includ
summari
recommend
seri
consult
sever
hundr
front
line
public
health
practition
target
countri
held
identifi
key
barrier
scale
evidencebas
intervent
reduc
pneumonia
diarrhea
mortal
critic
barrier
includ
absenc
nation
coordin
within
ministri
stakehold
deliv
intervent
insuffici
financi
resourc
inadequ
train
support
health
worker
poor
system
monitor
assess
key
programmat
indic
sporad
avail
key
commod
final
list
recommend
includ
improv
coordin
variou
group
work
prevent
treatment
intervent
control
pneumonia
diarrhea
substanti
increas
resourc
child
surviv
program
emphasi
pneumonia
diarrhea
control
effort
enhanc
effort
attract
train
retain
compet
work
forc
caregiv
invest
better
system
harmon
collect
essenti
programmat
indic
ensur
inform
share
throughout
system
strengthen
suppli
system
deliv
essenti
commod
summari
cost
achiev
end
prevent
death
pneumonia
diarrhea
estim
around
us
billion
despit
larg
reduct
child
mortal
allcaus
mortal
specif
diarrhea
pneumonia
associ
diseas
remain
caus
prevent
death
achiev
fourth
millennium
develop
goal
longerterm
target
reduct
child
mortal
death
fewer
per
live
birth
countri
requir
signific
decreas
mortal
diarrhea
